Celadon Pharmaceuticals (CEL) News Today GBX 13.80 -1.70 (-10.97%) (As of 08:35 AM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period AIM WINNERS & LOSERS: Judges Scientific down on "disappointing" tradeNovember 18 at 8:33 PM | lse.co.ukCeladon shares slump on little progress in financing talksNovember 18 at 8:33 PM | lse.co.ukCeladon Pharmaceuticals Faces Financial UncertaintiesNovember 18 at 8:33 PM | msn.comCeladon Pharmaceuticals (LON:CEL) Stock Price Up 1.8% - Time to Buy?November 16, 2024 | americanbankingnews.comCeladon Pharmaceuticals PLC (LSE:CEL) (H1 2024) Earnings Call Highlights: Strategic ...October 10, 2024 | finance.yahoo.comCeladon Pharmaceuticals Plc (CEL.L)October 6, 2024 | finance.yahoo.comCeladon Pharmaceuticals signs sales contract with Valeos PharmaOctober 2, 2024 | lse.co.ukEXECUTIVE CHANGES: Bank of Ireland promotes ex-Barclays exec to chairSeptember 30, 2024 | lse.co.ukRocket Panda Brings New Adventure to the Genesis and Mega DriveSeptember 19, 2024 | msn.comCeladon Pharmaceuticals shares dive as laments delayed fundingSeptember 11, 2024 | lse.co.ukUK Cannabis Firm Raises £1.05M Via Discounted Offering, Expands Partnership With Danish Medical Marijuana ProducerSeptember 11, 2024 | benzinga.comAIM WINNERS & LOSERS: Global Petroleum jumps on potential Namibia dealAugust 12, 2024 | lse.co.ukCeladon Pharmaceutical shares dive amid delayed receipt of fundsAugust 12, 2024 | lse.co.ukTRADING UPDATES: Celadon ships to US; Oxford BioDynamics-Goodbody pactMay 23, 2024 | lse.co.ukCeladon Pharmaceuticals PLC CELFebruary 28, 2024 | morningstar.comCeladon announces start of cannabis supply for two UK companiesDecember 14, 2023 | lse.co.ukTRADING UPDATES: Celadon Pharma raises GBP2.0 million via placingDecember 12, 2023 | lse.co.ukUK's First Medical Marijuana Clinical Trial Gets Underway: National Health Service Remains CautiousDecember 4, 2023 | msn.comCeladon shares rise on supply contract worth up to GBP26 millionNovember 16, 2023 | lse.co.ukCeladon Pharmaceuticals to Raise GBP1 Mln via Discounted Placing, SubscriptionOctober 13, 2023 | marketwatch.comCeladon Pharmaceuticals First Half 2023 Earnings: UK£0.07 loss per share (vs UK£0.25 loss in 1H 2022)October 1, 2023 | finance.yahoo.comCeladon Pharmaceuticals interim loss narrows; optimistic for futureSeptember 28, 2023 | lse.co.ukCeladon shares rise on second UK contract win for cannabis productSeptember 5, 2023 | lse.co.ukCeladon Pharmaceuticals Enters New Contract Worth Up to GBP1.2 Mln in RevenueSeptember 5, 2023 | marketwatch.comOwning 61% in Celadon Pharmaceuticals Plc (LON:CEL) means that insiders are heavily invested in the company's futureAugust 22, 2023 | finance.yahoo.comCEL.L - Celadon Pharmaceuticals PlcAugust 1, 2023 | ca.finance.yahoo.comCeladon receives approval for 5,000 patient clinical cannabis trialAugust 1, 2023 | lse.co.ukInvestors’ Chronicle: Oxford Metrics, N Brown, Celadon PharmaceuticalsJune 9, 2023 | finance.yahoo.comCeladon Pharmaceuticals loss widens; confident amid three-year dealJune 5, 2023 | lse.co.ukCeladon secures GBP7 million credit facility as product demand growsMay 30, 2023 | lse.co.ukCeladon Pharmaceuticals Shares Rise on New GBP7 Mln Line of CreditMay 30, 2023 | marketwatch.comCeladon signs commercial cannabis supply agreement with UK firmMay 24, 2023 | lse.co.ukCORRECT: Celadon signs commercial cannabis supply agreement in UKMay 24, 2023 | lse.co.ukC15 Solutions Anticipates Substantial Growth in European Cannabis Market Through Innovative Tech PlatformApril 20, 2023 | finance.yahoo.comJames Short Celadon Pharmaceuticals Plc's (LON:CEL) CEO is the most bullish insider, and their stock value gained 162%last weekMarch 15, 2023 | finance.yahoo.comFresh permit for cannabis lifts CeladonMarch 14, 2023 | thetimes.co.ukCeladon Pharmaceuticals Shares Jump as Sale of Pharmaceutical Cannabis Product GrantedMarch 14, 2023 | marketwatch.comCeladon wins right to cultivate and make medicinal cannabis oilJanuary 16, 2023 | thetimes.co.ukCeladon Pharma's Midlands UK Facility Gets GMP Registration By MHRA; Stock UpJanuary 16, 2023 | markets.businessinsider.comCeladon Pharmaceuticals Shares Rise After UK Quality Standard RegistrationJanuary 16, 2023 | marketwatch.comCast PVC Film Market 2022 Research Report Recent Developments, Size, Share, Growth Strategies, Segment by Type, Region and Future Forecast 2028November 2, 2022 | marketwatch.comEARNINGS UPDATES: Crestchic raises outlook on record year-to-dateOctober 1, 2022 | lse.co.ukSPOT APPOINTS SENIOR VICE PRESIDENT FOR HUMAN RESOURCESSeptember 9, 2022 | finance.yahoo.comInsights on the Swimwear Global Market to 2030 - Featuring Adidas, Wacoal Holdings, Nike and Swimwear Anywhere Among OthersAugust 21, 2022 | finance.yahoo.comCeladon Pharmaceuticals PLC (CEL)August 10, 2022 | investing.comCeladon Pharma. Regulatory NewsJuly 29, 2022 | lse.co.ukCeladon Pharmaceuticals PLC - Stock ChartJune 18, 2022 | morningstar.comUpdate on the RYAH Smart Inhaler: Trials, Studies, Approvals, and OpportunitiesJune 15, 2022 | apnews.com Get Celadon Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners… Claim your FREE 2024 Gold Guide CEL Media Mentions By Week CEL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CEL News Sentiment▼0.200.46▲Average Medical News Sentiment CEL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CEL Articles This Week▼40▲CEL Articles Average Week Get Celadon Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Beacon Energy News Today Curzon Energy News Today Vodafone Group Public News Today BT Group News Today BBGI Global Infrastructure News Today Pacific Horizon Investment Trust News Today Shield Therapeutics News Today Chill Brands Group News Today Haleon News Today Hikma Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:CEL) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celadon Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Celadon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
